Screen LibraryTotal synthesis of bioactive natural products /
Total Synthesis of Bioactive Natural Products provides step-by-step guidelines for effectively synthesizing the most promising bioactive agents from a broad range of natural products. Beginning with a concise background that outlines the benefits and challenges faced in effective synthesis, the book...
Saved in:
| Main Authors: | |
|---|---|
| Corporate Authors: | |
| Published: |
Elsevier,
|
| Publisher Address: | Amsterdam, Netherlands : |
| Publication Dates: | [2019] |
| Literature type: | eBook |
| Language: | English |
| Subjects: | |
| Online Access: |
https://www.sciencedirect.com/science/book/9780081028223 |
| Summary: |
Total Synthesis of Bioactive Natural Products provides step-by-step guidelines for effectively synthesizing the most promising bioactive agents from a broad range of natural products. Beginning with a concise background that outlines the benefits and challenges faced in effective synthesis, the book goes on to provide individual outlines for approximately 100 of the most promising bioactive agents. Taking a logical, user-friendly approach, the systematic name, compound class, structure, natural source, pharmaceutical potential and synthetic routes for each structure are detailed, with clear illustrations throughout, making this book an essential and practical guide for anyone working with both synthesis and natural products. |
| Carrier Form: | 1 online resource (xvi, 334 pages) : illustrations |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9780081028230 0081028237 |
| Index Number: | QP517 |
| CLC: | Q81 |
| Contents: |
Front Cover; Total Synthesis of Bioactive Natural Products; Copyright; Dedication; Contents; Foreword; Preface; References; Chapter One: Aeruginosins 298-A and B; References; Chapter Two: Ageladine A; References; Chapter Three: (+)-Ainsliadimer A; References; Chapter Four: ( -- )-Aiphanol; References; Chapter Five: (+)-Amphidinolide T1; References; Chapter Six: Ancistroealaine A and Ancistrotanzanine B; References; Chapter Seven: ( -- )-Andrographolide; References; Chapter Eight: Anolignan A; References; Chapter Nine: Anolignan B; References; Chapter Ten: Antrocamphin A; References Chapter Eleven: Arenamide AReferences; Chapter Twelve: Atroviridin; References; Chapter Thirteen: Bauhinoxepin J; References; Chapter Fourteen: Beta-Lapachone; References; Chapter Fifteen: Bombykol; References; Chapter Sixteen: Bulbophylol-B; References; Chapter Seventeen: Caminoside A; References; Chapter Eighteen: (+)-Chaetocin; References; Chapter Nineteen: Ciliatamides A and B; References; Chapter Twenty: Cylindol A; References; Chapter Twenty One: Daedalin A; References; Chapter Twenty Two: 6-Deoxypladienolide D; References Chapter Forty Seven: Paecilomycine AReferences; Chapter Forty Eight: Pochonin A; References; Chapter Forty Nine: Rhinacanthin A; References; Chapter Fifty: Rubriflordilactone A; References; Chapter Fifty One: (+)-Sattazolin; References; Chapter Fifty Two: Somocystinamide A; References; Chapter Fifty Three: ( -- )-Stagonolide A; References; Chapter Fifty Four: ( )-Steenkrotin A; References; Chapter Fifty Five: Thiaplakortone A and Its Semisynthetic Derivatives; References; Chapter Fifty Six: Vinigrol; References; Chapter Fifty Seven: Withaferin A; References; Chapter Fifty Eight: Withanolide A |